Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ninna Aggerholm-Pedersen (N Aggerholm-Pedersen, Ninna Aggerholm Pedersen)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Venues

Cancers

Acta oncologica (Stockholm, Sweden)

Journal of personalized medicine

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Iren Riskjell, Vivi-Nelli Mäkinen, Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen
Targeted Treatment of Soft-Tissue Sarcoma. Journal of personalized medicine 13 (5) (2023)
Anneli Dowler Nygaard, Ninna Aggerholm-Pedersen, Gitte Aarøe Dam, Marianne Marquard Knap, Elizaveta Mitkina Tabaksblat
Local disease control after stereotactic body radiotherapy in patients with neuroendocrine neoplasms: a cohort study. Acta oncologica (Stockholm, Sweden) (2023)
Jesper Geert Pedersen, Mateo Sokac, Boe Sandahl Sørensen, Adam Andrzej Luczak, Ninna Aggerholm-Pedersen, Nicolai Juul Birkbak, Trine Heide Øllegaard, Martin Roelsgaard Jakobsen
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma. Cancers 14 (14) (2022)
Charlotte Margareta Brinch, Estrid V S Høgdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers 14 (23) (2022)
Tatiana Georgiesh, Ninna Aggerholm-Pedersen, Patrick Schöffski, Yifan Zhang, Andrea Napolitano, Judith V M G Bovée, Åse Hjelle, Gordon Tang, Mateusz Spalek, Margherita Nannini, David Swanson, Thomas Baad-Hansen, Raf Sciot, Asle Charles Hesla, Paul Huang, Desiree Dorleijn, Hans Kristian Haugland, Maribel Lacambra, Jacek Skoczylas, Maria A Pantaleo, Rick L Haas, Leonardo A Meza-Zepeda, Florian Haller, Anna M Czarnecka, Herbert Ho-Fung Loong, Nina L Jebsen, Michiel van de Sande, Robin L Jones, Felix Haglund, Iris Timmermans, Akmal Safwat, Bodil Bjerkehagen, Kjetil Boye
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour. British journal of cancer 127 (10) (2022)
Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Mie Hessellund Samson, Holger Jon Møller
A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice. Cancers 14 (12) (2022)
Charlotte Margareta Brinch, Estrid V S Høgdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers 14 (23) (2022)
Charlotte Margareta Brinch, Estrid V S Høgdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers 14 (23) (2022)
Sidse Ehmsen, L H Jakobsen, M E Lendorf, R L Eefsen, L Bentsen, A S Knoop, Ninna Aggerholm-Pedersen, H Skuladottir, J Herrstedt, L H Jensen, C Rotbøl, M B Damm, K Wedervang, Andreas Glenthoej, Jesper Ryg, Henrik Frederiksen, Annette Raskov Kodahl
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study. Acta oncologica (Stockholm, Sweden) 60 (7) (2021)

Ninna Aggerholm-Pedersen.css-eqlu8i{font-size:small;padding-left:4px;} (N Aggerholm-Pedersen, Ninna Aggerholm Pedersen)

Publication Activity (10 Years)

Top Topics

Top Venues

Ninna Aggerholm-Pedersen (N Aggerholm-Pedersen, Ninna Aggerholm Pedersen)